Part 524 - OPHTHALMIC AND TOPICAL DOSAGE FORM NEW ANIMAL DRUGS
- Section 524.86 - Amitraz
- Section 524.154 - Bacitracin, neomycin, and polymyxin B ophthalmic ointment
- Section 524.155 - Bacitracin, neomycin, polymyxin B, and hydrocortisone ophthalmic ointment
- Section 524.230 - Buprenorphine
- Section 524.390 - Chloramphenicol ophthalmic ointment
- Section 524.402 - Chlorhexidine
- Section 524.450 - Clotrimazole
- Section 524.463 - Copper naphthenate
- Section 524.575 - Cyclosporine ophthalmic ointment
- Section 524.590 - Diclofenac
- Section 524.660 - Dimethyl sulfoxide
- Section 524.770 - Doramectin
- Section 524.775 - Emodepside and praziquantel
- Section 524.802 - Enrofloxacin and silver sulfadiazine otic emulsion
- Section 524.814 - Eprinomectin
- Section 524.815 - Eprinomectin and praziquantel
- Section 524.838 - Esafoxolaner, eprinomectin, and praziquantel
- Section 524.900 - Famphur
- Section 524.920 - Fenthion
- Section 524.955 - Florfenicol, terbinafine, and betamethasone acetate otic gel
- Section 524.957 - Florfenicol, terbinafine, and mometasone otic solution
- Section 524.960 - Flumethasone, neomycin, and polymyxin B ophthalmic solution
- Section 524.970 - Flunixin
- FLUOCINOLONE TOPICAL AND OTIC DOSAGE FORMS (§§ 524.981 — 524.2620)